SAM
CODX

Smartleaf Asset Management’s Co-Diagnostics CODX Stock Holding History

Smartleaf Asset Management’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$226 Hold
133
– – ﹤0.01% 3322
2025
Q4 		$723 Buy
+133
New +$1.45K ﹤0.01% 3216

Other funds holding CODX

PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Smartleaf Asset Management's CODX Position: Q1 2026 in Review

Smartleaf Asset Management held its Co-Diagnostics (CODX) position steady in Q1 2026 at 133 shares worth $226. The position accounts for ﹤0.01% of the portfolio, ranked #3322.

Smartleaf Asset Management first reported a position in CODX in Q4 2025 and has held it in 2 quarters since. The position peaked at $723 in Q4 2025. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Smartleaf Asset Management held 133 shares of Co-Diagnostics worth $226 as of Q1 2026.
  • Smartleaf Asset Management left its Co-Diagnostics share count unchanged in Q1 2026.
  • Co-Diagnostics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #3322 holding.
  • Smartleaf Asset Management first reported a position in Co-Diagnostics in Q4 2025 and has held it in 2 quarters since.
  • Smartleaf Asset Management's Co-Diagnostics position peaked at $723 in Q4 2025.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.